Literature DB >> 32761363

Prognostic usefulness of residual SYNTAX score combined with clinical factors for patients with acute coronary syndrome who underwent percutaneous coronary intervention from the SHINANO Registry.

Daisuke Kashiwagi1, Soichiro Ebisawa2, Hisanori Yui2, Shusaku Maruyama2, Ayumu Nagae2, Takahiro Sakai2, Tamon Kato2, Tatsuya Saigusa2, Ayako Okada2, Hirohiko Motoki2, Koichiro Kuwahara2.   

Abstract

The optimal strategy for percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS) with multi-vessel disease (MVD) is still controversial. Residual anatomical features alone are not sufficient to appropriately stratify patient risk. Our aim was to assess the effectiveness of the residual Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery (SYNTAX) score (rSS) combined with clinical factors to predict long-term clinical outcomes in ACS patients. A total of 120 patients with ACS and MVD undergoing PCI were recruited from the SHINANO 5-year registry: a prospective, multi-center, cohort study. The rSS combined with clinical factors (Combined Score) were calculated based on the residual coronary angiogram and each clinical feature after primary PCI. The Combined Score was calculated by replacing SS with rSS using the SYNTAX score II (SSII) calculator. We grouped the Combined Score in two groups according to the cut-off value calculated by the ROC curve (the C-statistic was 0.82 [95% CI 0.74-0.91]) for all-cause mortality. The primary endpoint was all-cause mortality during the 5-year follow-up. The Combined Score was associated with long-term mortality in Cox-regression analysis (HR 1.08, 95% CI 1.05-1.11, P < 0.001). The mortality rate was significantly higher in the high-score group compared with the low-score group (5.7% vs 38.0%; P < 0.001). In ACS with MVD, the Combined Score might be considered an important tool to predict long-term mortality following PCI.

Entities:  

Keywords:  Acute coronary syndrome; Multi-vessel coronary disease; Percutaneous coronary intervention; Residual SYNTAX score

Mesh:

Year:  2020        PMID: 32761363     DOI: 10.1007/s00380-020-01680-3

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  2 in total

1.  Impact of the Residual SYNTAX Score on Outcomes of Revascularization in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease.

Authors:  Mohamed Loutfi; Sherif Ayad; Mohamed Sobhy
Journal:  Clin Med Insights Cardiol       Date:  2016-03-09

2.  Prognostic Value of SYNTAX Score II in Patients with Acute Coronary Syndromes Referred for Invasive Management: A Subanalysis from the SPUM and COMFORTABLE AMI Cohorts.

Authors:  Slayman Obeid; Antonio H Frangieh; Lorenz Räber; Nooraldaem Yousif; Thomas Gilhofer; Kyohei Yamaji; Milosz Jaguszewski; Soheila Aghlmandi; James Adams; Yannik Bockhorn; Christian Templin; Barbara E Stähli; Peter Jüni; Nicolas Rodondi; François Mach; Marco Roffi; Stephan Windecker; Willibald Maier; Fabian Nietlispach; Christian M Matter; Roland Klingenberg; Thomas F Lüscher
Journal:  Cardiol Res Pract       Date:  2018-09-25       Impact factor: 1.866

  2 in total
  2 in total

1.  The Predictive Value of Combining Symptoms, Residual Syntax Score and Non-Invasive Tests in the Diagnosis of Significant Coronary Artery Disease in Elderly Post-PCI Patients.

Authors:  Jing Zhang; Yuxi Li; Bo Zheng; Jianxing Qiu; Xiahuan Chen; Weiwei Zhou; Yan Fan; Meilin Liu
Journal:  Int J Gen Med       Date:  2022-05-03

2.  The Incremental Prognostic Value of the Clinical Residual SYNTAX Score for Patients With Chronic Renal Insufficiency Undergoing Percutaneous Coronary Intervention.

Authors:  Liqiu Yan; Peiyao Li; Yabin Wang; Dong Han; Sulei Li; Min Jiang; Xufen Cao; Feng Cao
Journal:  Front Cardiovasc Med       Date:  2021-04-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.